Certain biomarkers and biophysical measurements used to detect PE, such as PAPP-A, MAP and UtA-PI, have biological plausibility for GDM, and may be useful to incorporate in a consolidated, cost-effective approach to early screening for composite pregnancy complications [36]. Here, PAPPA is linked to gestational diabetes.